Insights

Innovative Drug Delivery AcousticaBio specializes in transforming biologic drug formulations into small-volume, highly concentrated subcutaneous injections, presenting a significant opportunity to partner with pharmaceutical companies aiming to improve patient compliance and reduce administration costs.

Therapeutic Diversification The company's versatile acoustophoretic platform can be applied across multiple therapeutic areas beyond monoclonal antibodies, offering potential to expand collaborations with biopharmaceutical firms developing a broad range of biologic therapies.

Growth Potential With revenues between 1 million and 10 million dollars and a focused team, AcousticaBio presents an attractive prospect for investors or partners seeking companies with innovative technology poised for market expansion in drug delivery solutions.

Technology Differentiator Utilizing Harvard-patented acoustophoretic technology and advanced microparticle manufacturing, AcousticaBio has a competitive edge that can be leveraged in sales pitches to biopharma companies looking for cutting-edge solutions to improve drug formulation and patient administration.

Collaborative Opportunities The company's emphasis on partnerships to advance therapeutic products indicates strong potential for B2B collaborations, licensing, or co-development deals with organizations seeking innovative delivery platforms to enhance their pipeline and patient outcomes.

Similar companies to AcousticaBio

AcousticaBio Tech Stack

AcousticaBio uses 8 technology products and services including Webpack, Module Federation, Wix eCommerce, and more. Explore AcousticaBio's tech stack below.

  • Webpack
    Development
  • Module Federation
    Development
  • Wix eCommerce
    E-commerce
  • React
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • WebsiteBuilder
    Page Builders
  • Priority Hints
    Performance
  • WordPress.com
    Platform As A Service

Media & News

AcousticaBio's Email Address Formats

AcousticaBio uses at least 1 format(s):
AcousticaBio Email FormatsExamplePercentage
First.Last@acoustica.bioJohn.Doe@acoustica.bio
50%
First.Last@acoustica.bioJohn.Doe@acoustica.bio
50%

Frequently Asked Questions

Where is AcousticaBio's headquarters located?

Minus sign iconPlus sign icon
AcousticaBio's main headquarters is located at 277 Broadway, 1st Floor. The company has employees across 1 continents, including North America.

What is AcousticaBio's official website and social media links?

Minus sign iconPlus sign icon
AcousticaBio's official website is acoustica.bio and has social profiles on LinkedInCrunchbase.

What is AcousticaBio's SIC code NAICS code?

Minus sign iconPlus sign icon
AcousticaBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AcousticaBio have currently?

Minus sign iconPlus sign icon
As of January 2026, AcousticaBio has approximately 14 employees across 1 continents, including North America. Key team members include Ceo & Founder: D. F.Business Operations Manager: J. L.Mentor: W. O.. Explore AcousticaBio's employee directory with LeadIQ.

What industry does AcousticaBio belong to?

Minus sign iconPlus sign icon
AcousticaBio operates in the Biotechnology Research industry.

What technology does AcousticaBio use?

Minus sign iconPlus sign icon
AcousticaBio's tech stack includes WebpackModule FederationWix eCommerceReactPolyfillWebsiteBuilderPriority HintsWordPress.com.

What is AcousticaBio's email format?

Minus sign iconPlus sign icon
AcousticaBio's email format typically follows the pattern of First.Last@acoustica.bio. Find more AcousticaBio email formats with LeadIQ.

When was AcousticaBio founded?

Minus sign iconPlus sign icon
AcousticaBio was founded in 2021.

AcousticaBio

Biotechnology ResearchMassachusetts, United States11-50 Employees

We are an advanced manufacturing company solving the greatest challenges in drug delivery for novel therapeutics. Today, millions of patients face the burden of frequent hospital visits, enduring painful, costly, and time-consuming intravenous injections to receive their life-saving medications. AcousticaBio transforms this process, making drug delivery as simple as receiving a routine flu shot.
 
Utilizing advanced microparticle technology and our Harvard-patented acoustophoretic platform, we convert intravenously delivered biologic products into highly concentrated, small-volume subcutaneous injections - all without the use of solvents or cumbersome post-processing. Our versatile technology extends beyond monoclonal antibodies, offering an unparalleled ability to formulate a wide range of materials across multiple therapeutic areas.
 
We are committed to collaborating with biopharmaceutical partners to advance their products, improve the quality of care, and enable patients to self-administer their life-saving medications from the comfort of their homes. Join us at AcousticaBio, where we value how work gets done just as much as what ultimately gets accomplished.

Section iconCompany Overview

Headquarters
277 Broadway, 1st Floor
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    AcousticaBio's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    AcousticaBio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.